The Link Between Endoplasmic Reticulum Stress and Lysosomal Dysfunction Under Oxidative Stress in Cancer Cells
Biomolecules · 25.06.2025 · 15 (7) · 930
DOI: 10.3390/biom15070930 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 25.06.2025. Verfasst von Mariapia Vietri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, SA, Italy. Hauptthemen laut MEDLINE: Oxidative Stress, Endoplasmic Reticulum Stress, Neoplasms, Lysosomes. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lysosomal dysfunction and endoplasmic reticulum (ER) stress play essential roles in cancer cell survival, growth, and stress adaptation. Among the various stressors in the tumor microenvironment, oxidative stress (OS) is a central driver that exacerbates both lysosomal and ER dysfunction. In healthy cells, the ER manages protein folding and redox balance, while lysosomes regulate autophagy and degradation. Cancer cells, however, are frequently exposed to elevated levels of reactive oxygen species (ROS), which disrupt protein folding in the ER and damage lysosomal membranes and enzymes, promoting dysfunction. Persistent OS activates the unfolded protein response (UPR) and contributes to lysosomal membrane permeabilization (LMP), leading to pro-survival autophagy or cell death depending on the context and on the modulation of pathways like PERK, IRE1, and ATF6. Cancer cells exploit these pathways by enhancing their tolerance to OS and shifting UPR signaling toward survival. Moreover, lysosomal impairment due to ROS accumulation compromises autophagy, resulting in the buildup of damaged organelles and further amplifying oxidative damage. This vicious cycle of ROS-induced ER stress and lysosomal dysfunction contributes to tumor progression, therapy resistance, and metabolic adaptation. Thus, targeting lysosomal and ER stress responses offers potential as cancer therapy, particularly in increasing oxidative stress and promoting apoptosis. This review explores the interconnected roles of lysosomal dysfunction, ER stress, and OS in cancer, focusing on the mechanisms driving their crosstalk and its implications for tumor progression and therapeutic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, SA, Italy.
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana"/DIPMED, Via S. Allende, 84081 Baronissi, SA, Italy.
ORCID-Profile: Maria Rosaria Miranda, Giuseppina Amodio, Tania Ciaglia, Pietro Campiglia, Paolo Remondelli, Vincenzo Vestuto, Ornella Moltedo
Zitieren
APA
Vietri, M., Miranda, M. R., Amodio, G., Ciaglia, T., Bertamino, A., Campiglia, P., Remondelli, P., Vestuto, V., & Moltedo, O. (2025). The Link Between Endoplasmic Reticulum Stress and Lysosomal Dysfunction Under Oxidative Stress in Cancer Cells. Biomolecules, 15(7), 930. https://doi.org/10.3390/biom15070930
Vancouver
Vietri M, Miranda MR, Amodio G, Ciaglia T, Bertamino A, Campiglia P, et al. The Link Between Endoplasmic Reticulum Stress and Lysosomal Dysfunction Under Oxidative Stress in Cancer Cells. Biomolecules. 2025;15(7):930. doi:10.3390/biom15070930
BibTeX
@article{Vietri2025,
author = {Vietri, Mariapia and Miranda, Maria Rosaria and Amodio, Giuseppina and Ciaglia, Tania and Bertamino, Alessia and Campiglia, Pietro and Remondelli, Paolo and Vestuto, Vincenzo and Moltedo, Ornella},
title = {The Link Between Endoplasmic Reticulum Stress and Lysosomal Dysfunction Under Oxidative Stress in Cancer Cells},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {7},
pages = {930},
doi = {10.3390/biom15070930}
}
EUVIMED